Log In
Print this Print this

Epicutaneous immunotherapy, Viaskin-OVA

  Manage Alerts
Collapse Summary General Information
Company DBV Technologies S.A.
DescriptionViaskin patch containing ovalbumin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationCrohn's disease
Indication DetailsTreat Crohn's disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today